BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
See today's BioWorld Asia
Home
» Other news to note for March 24, 2026
To read the full story,
subscribe
or
sign in
.
Other news to note for March 24, 2026
March 24, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: A.D.A.M. Innovations, Cipla, Co-Diagnostics, Cosara Diagnostics, Daiichi Sankyo, Egret, Fennec, Genexine, Hamamatsu Photonics, HCW Biologic, Leveragen, Oxford Nanopore Technologies, PRG S&T, Sakura Finetek, Samsung Bioepis, Sandoz, Sentynl, Trimmune, Voro, Zydus.
BioWorld Asia
Briefs
Other news to note